Author

F. Royer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cell type annotation· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. D. Gingerich· 4 shared J. Huang· 2 shared J. J. Mousa· 2 shared J. Mousa· 2 shared A. B. Ward· 1 shared A. Banerjee· 1 shared A. L. McCormick· 1 shared A. Pena-Briseno· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

A. D. Gingerich

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Synergistic protection against secondary pneumococcal infection by human monoclonal antibodies targeting distinct epitopes

A. D. Gingerich, F. Royer, A. L. McCormick, A. Scasny, J. E. Vidal, J. Mousa

This paper demonstrates that two human monoclonal antibodies targeting distinct epitopes of pneumococcal surface protein PhtD synergistically protect against secondary pneumococcal infection in a mouse model.

bioRxiv · Apr 20, 2022Immunology

Structural basis for ultrapotent neutralization of human metapneumovirus

A. Banerjee, J. Huang, S. Rush, J. Murray, A. D. Gingerich, F. Royer, C.-L. Hsieh, R. A. Tripp, J. S. McLellan, J. J. Mousa

This study identifies a potent monoclonal antibody against hMPV and determines its structure, revealing a novel epitope for therapeutic development.

bioRxiv · Mar 14, 2022 · PreprintImmunology

The pre-existing human antibody repertoire to computationally optimized influenza H1 hemagglutinin vaccines

K. Nagashima, J. V. Dzimianski, J. Han, N. Abbadi, A. D. Gingerich, F. Royer, S. O'Rourke, G. A. Sautto, T. M. Ross, A. B. Ward, R. M. DuBois, J. Mousa

This study identifies pre-existing human B cell responses to computationally optimized H1 hemagglutinin vaccines, showing cross-reactivity and functional antibodies targeting head, central stalk, and anchor epitopes.

bioRxiv · Oct 25, 2021Immunology

Broadly reactive human monoclonal antibodies targeting the pneumococcal histidine triad protein protect against fatal pneumococcal infection

J. Huang, A. D. Gingerich, F. Royer, A. V. Paschall, A. Pena-Briseno, F. Y. Avci, J. J. Mousa

The paper isolates human monoclonal antibodies against pneumococcal proteins PhtD and PspA, showing protection against pneumococcal infection in mice.

bioRxiv · Feb 17, 2021Immunology